Viewing Study NCT05942768


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-02-09 @ 1:57 AM
Study NCT ID: NCT05942768
Status: COMPLETED
Last Update Posted: 2023-07-12
First Post: 2023-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Sponsor: Hunan Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Colorectal cancer;regorafenib;anti-PD-1 antibodies View